Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Lan Lu

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 4, 2012
Seroprevalence of hepatitis virus infection in men who have sex with men aged 18-40 years in TaiwanYu-Tzu Tseng, Hsin-Yun Sun, Sui-Yuan Chang, et al.
The Journal of Experimental Medicine|July 28, 2019
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoirChristian Gaebler, Julio C C Lorenzi, Thiago Y Oliveira, et al.
Journal of Clinical Microbiology|December 23, 2011
Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factorsHsin-Yun Sun, Sui-Yuan Chang, Zong-Yu Yang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 29, 2011
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemiaChing-Lan Lu, Yu-Hui Lin, Wing-Wai Wong, et al.
Vaccine|April 10, 2012
Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patientsChing-Lan Lu, Chien-Ching Hung, Yu-Chung Chuang, et al.
Nature Medicine|February 5, 2020
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunityJulia Niessl, Amy E Baxter, Pilar Mendoza, et al.
Science (New York, N.Y.)|May 21, 2016
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivoChing-Lan Lu, Dariusz K Murakowski, Stylianos Bournazos, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Relationship between intact HIV-1 proviruses in circulating CD4<sup>+</sup> T cells and rebound viruses emerging during treatment interruptionChing-Lan Lu, Joy A Pai, Lilian Nogueira, et al.
Cell|August 1, 2017
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In VivoJoshua A Horwitz, Yotam Bar-On, Ching-Lan Lu, et al.
Pancreas|February 21, 2012
Incidence of acute pancreatitis in human immunodeficiency virus-positive patients with hypertriglyceridemia: is it really high?Hsin-Yun Sun, Sui-Yuan Chang, Wang-Huei Sheng, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 4, 2012
Seroprevalence of hepatitis virus infection in men who have sex with men aged 18-40 years in TaiwanYu-Tzu Tseng, Hsin-Yun Sun, Sui-Yuan Chang, et al.
The Journal of Experimental Medicine|July 28, 2019
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoirChristian Gaebler, Julio C C Lorenzi, Thiago Y Oliveira, et al.
Journal of Clinical Microbiology|December 23, 2011
Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factorsHsin-Yun Sun, Sui-Yuan Chang, Zong-Yu Yang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 29, 2011
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemiaChing-Lan Lu, Yu-Hui Lin, Wing-Wai Wong, et al.
Vaccine|April 10, 2012
Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patientsChing-Lan Lu, Chien-Ching Hung, Yu-Chung Chuang, et al.
Nature Medicine|February 5, 2020
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunityJulia Niessl, Amy E Baxter, Pilar Mendoza, et al.
Science (New York, N.Y.)|May 21, 2016
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivoChing-Lan Lu, Dariusz K Murakowski, Stylianos Bournazos, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Relationship between intact HIV-1 proviruses in circulating CD4<sup>+</sup> T cells and rebound viruses emerging during treatment interruptionChing-Lan Lu, Joy A Pai, Lilian Nogueira, et al.
Cell|August 1, 2017
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In VivoJoshua A Horwitz, Yotam Bar-On, Ching-Lan Lu, et al.
Pancreas|February 21, 2012
Incidence of acute pancreatitis in human immunodeficiency virus-positive patients with hypertriglyceridemia: is it really high?Hsin-Yun Sun, Sui-Yuan Chang, Wang-Huei Sheng, et al.
Pageof 3